TA
ABMD

Thor Advisors’s Abiomed Inc ABMD Stock Holding History

Thor Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$14K Buy
+50
New +$16.6K 0.17% 162

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Thor Advisors's ABMD Position: Q1 2019 in Review

Thor Advisors opened a new position in Abiomed Inc (ABMD) in Q1 2019: 50 shares worth $14K. The stake represents 0.17% of the portfolio and ranks #162 among its holdings.

559 funds tracked by Wall St. Rank hold ABMD as of Q1 2019.

  • Thor Advisors held 50 shares of Abiomed Inc worth $14K as of Q1 2019.
  • Abiomed Inc was a new Thor Advisors position in Q1 2019.
  • Abiomed Inc made up 0.17% of Thor Advisors's portfolio in Q1 2019, its #162 holding.
  • 559 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2019.

Based on Thor Advisors's 13F filing for Q1 2019, filed 12 Jun 2019.